Lee E. Schechter

Best Publications

• βSubunits Promote K+ Channel Surface Expression through Effects Early in Biosynthesis

  Gongyi Shi;Kensuke Nakahira;Scott Hammond;Kenneth J Rhodes

  484
  Citations

• Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications

  Robert H. Ring;Jessica E. Malberg;Lisa Potestio;Julia Ping

  381
  Citations

• From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes.

  Darlene Deecher;Terrance H. Andree;Diane Sloan;Lee E. Schechter

  335
  Citations

• Innovative Approaches for the Development of Antidepressant Drugs: Current and Future Strategies

  Lee E. Schechter;Robert H. Ring;Chad E. Beyer;Zoë A. Hughes

  322
  Citations

• Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.

  Lee E Schechter;Qian Lin;Deborah L Smith;Guoming Zhang

  293
  Citations

• The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.

  Unknown

  245
  Citations

• Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.

  Darrick T. Balu;Brian A. Hoshaw;Jessica E. Malberg;Sharon Rosenzweig-Lipson

  237
  Citations

• Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs

  Jessica E Malberg;Lee E Schechter

  230
  Citations

• Voltage-Gated K+ Channel β Subunits: Expression and Distribution of Kvβ1 and Kvβ2 in Adult Rat Brain

  Kenneth J. Rhodes;Michael M. Monaghan;Nestor X. Barrezueta;Stanley Nawoschik

  212
  Citations

• Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties

  Lee E Schechter;Deborah Smith;Sharon Rosenzweig-Lipson;Stacey Sukoff

  195
  Citations

• The Central 5‐HT1A Receptors: Pharmacological, Biochemical, Functional, and Regulatory Propertiesa

  M. Hamon;H. Gozlan;S. El Mestikawy;M. B. Emerit

  188
  Citations

• Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist

  Robert H. Ring;Lee E. Schechter;Sarah K. Leonard;Jason M. Dwyer

  171
  Citations

• Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.

  Sarah K. Leonard;Jason M. Dwyer;Stacey J. Sukoff Rizzo;Brian Platt

  164
  Citations

• Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.

  L E Schechter;F J Bolaños;H Gozlan;L Lanfumey

  151
  Citations

• Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists.

  Derek C. Cole;William J. Lennox;Sabrina Lombardi;John W. Ellingboe

  147
  Citations

• WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity

  John Dunlop;Annmarie L. Sabb;Hossein Mazandarani;Jean Zhang

  145
  Citations

• The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s disease.

  L.E. Schechter;L.A. Dawson;Josie A. Harder

  142
  Citations

• Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects

  Jessica E Malberg;Brian Platt;Stacey J Sukoff Rizzo;Robert H Ring

  126
  Citations

• WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.

  Zoë A. Hughes;Feng Liu;Brian J. Platt;Jason M. Dwyer

  122
  Citations

• Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats.

  Gregory V. Carr;Lee E. Schechter;Irwin Lucki

  111
  Citations